Pharming (PHAR) Net Income (2020 - 2025)
Historic Net Income for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to $25.0 million.
- Pharming's Net Income rose 27524.04% to $25.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.4 million, marking a year-over-year increase of 15647.29%. This contributed to the annual value of -$12.0 million for FY2024, which is 20512.36% down from last year.
- As of Q3 2025, Pharming's Net Income stood at $25.0 million, which was up 27524.04% from $9.4 million recorded in Q2 2025.
- In the past 5 years, Pharming's Net Income ranged from a high of $25.6 million in Q2 2021 and a low of -$22.5 million during Q2 2024
- Moreover, its 5-year median value for Net Income was $884013.0 (2021), whereas its average is $378790.3.
- As far as peak fluctuations go, Pharming's Net Income plummeted by 28390.75% in 2021, and later soared by 2476194.35% in 2022.
- Pharming's Net Income (Quarter) stood at $15.2 million in 2021, then plummeted by 210.61% to -$16.8 million in 2022, then soared by 59.22% to -$6.9 million in 2023, then rose by 10.86% to -$6.1 million in 2024, then surged by 508.97% to $25.0 million in 2025.
- Its Net Income stands at $25.0 million for Q3 2025, versus $9.4 million for Q2 2025 and -$3.9 million for Q1 2025.